Efficiency of a Guiding Device for Inferior Alveolar Nerve Block, EZ-Block®, Compared to a Conventional Freehand Administration.
Launched by ELSAN · Jan 28, 2022
Trial Information
Current as of September 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the EZ-BLOCK® that helps dentists deliver anesthesia for tooth extractions more effectively than the traditional method, known as freehand administration. The goal is to see if using this guiding device can improve the success of numbing the area around the lower jaw, especially for patients having their wisdom teeth removed. Current methods can vary in how well they work, and the EZ-BLOCK® aims to provide a more reliable and personalized approach based on each patient's unique anatomy.
To participate in the trial, you need to be at least 18 years old and have recent dental images showing your wisdom teeth. Additionally, both of your lower wisdom teeth should have similar characteristics to be eligible. If you're pregnant, allergic to anesthesia, or have certain health conditions, you may not be able to join. If you take part, you'll receive either the EZ-BLOCK® technique or the traditional method and will be monitored throughout the process, helping researchers determine which method is more effective for numbing the area before tooth removal.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male or female, 18 years of age or older
- • 2. Dental panoramic radiograph or cone beam examination less than 6 months prior to inclusion
- 3. Clinical criteria and similar radiographs of the 2 mandibular third molars:
- • 1. Stage of root planing
- • 2. Normoposition, horizontal
- • 3. Type of eruption: disincluded, impacted, impacted
- • 4. Anatomical relationship between inferior alveolar nerve and mandibular wisdom tooth apices similar for both sides
- • 4. Affiliation to a social security scheme
- • 5. Informed consent, dated and signed before any study procedure is performed
- Exclusion Criteria:
- • 1. Pregnant or breastfeeding woman
- • 2. Known allergy to the anesthetic molecule or to a component of the anesthetic carpule
- • 3. Contraindication to the use of vasoconstrictor in dental anesthesia
- • 4. Contraindication to a therapeutic procedure under local anesthesia
- • 5. Patients taking TKA for another medical reason
- • 6. Presence of a cystic pathology related to at least 1 of the 2 mandibular third molars to be extracted
- • 7. Limitation of mouth opening
- • 8. Associated systemic pathology requiring priority management
- • 9. Inability of the patient to comply with study follow-up and scheduled visits (especially for second wisdom tooth avulsion)
- • 10. Patient under legal protection
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, France
Nancy, France
Paris, France
Strasbourg, France
Toulouse, France
Toulouse, France
Patients applied
Trial Officials
Marie-Alix Fauroux, MD
Study Director
CHU Montpellier - UFR Odontologie de Montpellier
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials